Armata Pharmaceuticals, Inc. (ARMP)
5.84
+0.32
(+5.80%)
USD |
NYAM |
Sep 04, 16:00
5.83
-0.01
(-0.17%)
After-Hours: 20:00
Armata Pharmaceuticals Total Assets (Quarterly) : 89.95M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 89.95M |
| March 31, 2026 | 69.80M |
| December 31, 2025 | 86.19M |
| September 30, 2025 | 89.52M |
| June 30, 2025 | 80.79M |
| March 31, 2025 | 87.25M |
| December 31, 2024 | 99.33M |
| September 30, 2024 | 98.24M |
| June 30, 2024 | 108.31M |
| March 31, 2024 | 120.36M |
| December 31, 2023 | 109.96M |
| September 30, 2023 | 112.76M |
| June 30, 2023 | 101.21M |
| March 31, 2023 | 108.78M |
| December 31, 2022 | 107.88M |
| September 30, 2022 | 92.88M |
| June 30, 2022 | 100.98M |
| March 31, 2022 | 107.76M |
| December 31, 2021 | 79.80M |
| September 30, 2021 | 42.67M |
| June 30, 2021 | 48.28M |
| March 31, 2021 | 52.84M |
| December 31, 2020 | 42.54M |
| September 30, 2020 | 45.68M |
| June 30, 2020 | 49.46M |
| Date | Value |
|---|---|
| March 31, 2020 | 44.10M |
| December 31, 2019 | 25.45M |
| September 30, 2019 | 29.30M |
| June 30, 2019 | 34.92M |
| March 31, 2019 | 9.617M |
| December 31, 2018 | 14.54M |
| September 30, 2018 | 10.62M |
| June 30, 2018 | 11.72M |
| March 31, 2018 | 14.40M |
| December 31, 2017 | 11.14M |
| September 30, 2017 | 13.78M |
| June 30, 2017 | 15.11M |
| March 31, 2017 | 14.30M |
| December 31, 2016 | 18.20M |
| September 30, 2016 | 26.04M |
| June 30, 2016 | 29.28M |
| March 31, 2016 | 28.26M |
| December 31, 2015 | 31.49M |
| September 30, 2015 | 34.08M |
| June 30, 2015 | 36.37M |
| March 31, 2015 | 38.60M |
| December 31, 2014 | 28.62M |
| September 30, 2014 | 31.93M |
| June 30, 2014 | 34.72M |
| March 31, 2014 | 34.25M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 321.12M |
| Shareholders Equity (Quarterly) | -231.17M |
| Debt to Equity Ratio | -1.358 |
| Current Ratio | 0.1085 |
| Net Debt Paydown Yield | -14.90% |